Detection and analysis of nanoparticles in patients: A critical review of the status quo of clinical nanotoxicology

Biomaterials

Volumn 76, Issue , 2016, Pages 302-312

  Bitounis, Dimitrios ^a   Pourchez, Jérémie ^b   Forest, Valérie ^b   Boudard, Delphine ^a   Cottier, Michèle ^a   Klein, Jean Philippe ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b ECOLE DES MINES DE SAINT ETIENNE   (France)

Author keywords

Analysis; Clinical; Nanoparticles; Nanotoxicology; Qualitative; Quantitative

Indexed keywords

NANOPARTICLES;

ANALYSIS; CLINICAL; NANOTOXICOLOGY; QUALITATIVE; QUANTITATIVE;

CHEMICAL ANALYSIS;

NANOPARTICLE;

ANALYTIC METHOD; CHEMICAL ANALYSIS; NANOTOXICOLOGY; PARTICLE SIZE; POLLUTANT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; HUMAN; PATIENT;

HUMANS; NANOPARTICLES; PATIENTS;

EID: 84961589790     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.10.061     Document Type: Review

References (77)

1. European Commision: Institute for Reference Materials and Measurements. Requirements on Measurements for the Implementation of the European Commission Definition of the Term "nanomaterial". European Union: JRC Publications. Online. 2012 September. Available from URL: . http://publications.jrc.ec.europa.eu/repository/handle/JRC73260.
2. European Commision: Institute for Reference Materials and Measurements. Towards a review of the EC Recommendation for a definition of the term "nanomaterial". European Union: JRC Publications. Online. 2014. Available from URL: . https://ec.europa.eu/jrc/en/publication/eur-scientific-and-technical-research-reports/towards-review-ec-recommendation-definition-term-nanomaterial-part-2-assessment-collected.
3. Chatterjee R. Calculating the costs of nanohazard testing. Environ. Sci. Technol. 2009, 43:3405.
4. Helland A., Scheringer M., Siegrist M., Kastenholz H.G., Wiek A., Scholz R.W. Risk assessment of engineered nanomaterials: a survey of industrial approaches. Environ. Sci. Technol. 2008, 42:640-646.
5. Wagner J.C., Sleggs C.A., Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br. J. Ind. Med. 1960, 17:260-271.
6. Berman D.W., Crump K.S. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit. Rev. Toxicol. 2008, 38:49-73.
7. Schinwald A., Murphy F., Prina-Mello A., Poland C., Byrne F., Glass J., et al. The threshold length for fibre-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol. Sci. 2012, 128:461-470.
8. Donaldson K., Murphy F.A., Duffin R., Poland C.A. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part. Fibre Toxicol. 2010, 7.
9. Donaldson K., Poland C.A., Murphy F.A., MacFarlane M., Chernova T., Schinwald A. Pulmonary toxicity of carbon nanotubes and asbestos - similarities and differences. Adv. Drug Deliv. Rev. 2013, 65:2078-2086.
10. Brauer M., Avila-Casado C., Fortoul T.I., Vedal S., Stevens B., Churg A. Air pollution and retained particles in the lung. Environ. Health Perspect. 2001, 109:1039-1043.
11. Araujo J.A., Barajas B., Kleinman M., Wang X., Bennett B.J., Gong K.W., et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ. Res. 2008, 102:589-596.
12. von der Kammer F., Ferguson P.L., Holden P.A., Masion A., Rogers K.R., Klaine S.J., et al. Analysis of engineered nanomaterials in complex matrices (environment and biota): general considerations and conceptual case studies. Environ. Toxicol. Chem. 2012, 31:32-49.
13. Malysheva A., Lombi E., Voelcker N.H. Bridging the divide between human and environmental nanotoxicology. Nat. Nanotechnol. 2015, 10:835-844.
14. Bozic K.J., Ong K., Lau E., Kurtz S.M., Vail T.P., Rubash H.E., et al. Risk of complication and revision total hip arthroplasty among Medicare patients with different bearing surfaces. Clin. Orthop. Relat. Res. 2010, 468:2357-2362.
15. Ingham E., Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials 2005, 26:1271-1286.
16. Keegan G.M., Learmonth I.D., Case C.P. Orthopaedic metals and their potential toxicity in the arthroplasty patient: a review of current knowledge and future strategies. J. Bone Jt. Surg. Br. 2007, 89:567-573.
17. Revell P.A., al-Saffar N., Kobayashi A. Biological reaction to debris in relation to joint prostheses. Proc. Inst. Mech. Eng. H 1997, 211:187-197.
18. Williams S., Tipper J.L., Ingham E., Stone M.H., Fisher J. In vitro analysis of the wear, wear debris and biological activity of surface-engineered coatings for use in metal-on-metal total hip replacements. Proc. Inst. Mech. Eng. H 2003, 217:155-163.
19. Allen M.J., Myer B.J., Millett P.J., Rushton N. The effects of particulate cobalt, chromium and cobalt-chromium alloy on human osteoblast-like cells in vitro. J. Bone Jt. Surg. Br. 1997, 79:475-482.
20. Rodgers K., Klykken P., Jacobs J., Frondoza C., Tomazic V., Zelikoff J. Immunotoxicity of medical devices. Symposium overview. Fundam. Appl. Toxicol. 1997, 36:1-14.
21. Yang S.Y., Ren W., Park Y., Sieving A., Hsu S., Nasser S., et al. Diverse cellular and apoptotic responses to variant shapes of UHMWPE particles in a murine model of inflammation. Biomaterials 2002, 23:3535-3543.
22. Tsaousi A., Jones E., Case C.P. The in vitro genotoxicity of orthopaedic ceramic (Al2O3) and metal (CoCr alloy) particles. Mutat. Res. 2010, 697:1-9.
23. Elder A., Vidyasagar S., DeLouise L. Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers. WIREs Nanomed. Nanobiotechnol. 2009, 1:434-450.
24. Bos I., Johannisson R. Foreign body reactions in lymph nodes of oncology patients with joint prostheses - light-, electron microscopic and immunohistological investigations. Pathol. Res. Pract. 2004, 200:189-196.
25. Urban R.M., Jacobs J.J., Tomlinson M.J., Gavrilovic J., Black J., Peoc'h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J. Bone Jt. Surg. Am. 2000, 82:457-476.
26. Urban R.M., Tomlinson M.J., Hall D.J., Jacobs J.J. Accumulation in liver and spleen of metal particles generated at nonbearing surfaces in hip arthroplasty. J. Arthroplast. 2004, 19:94-101.
27. Niedzwiecki S., Klapperich C., Short J., Jani S., Ries M., Pruitt L. Comparison of three joint simulator wear debris isolation techniques: acid digestion, base digestion, and enzyme cleavage. J. Biomed. Mater. Res. 2001, 56:245-249.
28. Baxter R.M., Steinbeck M.J., Tipper J.L., Parvizi J., Marcolongo M., Kurtz S.M. Comparison of periprosthetic tissue digestion methods for ultra-high molecular weight polyethylene wear debris extraction. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 91:409-418.
29. Šlouf M., Šloufová I., Horak Z., Štépánek P., Entlicher G., Krejčík M., et al. New fast method for determination of number of UHMWPE wear particles. J. Mater. Sci. Mater. Med. 2004, 15:1267-1278.
30. Milošev I., Remškar M. In vivo production of nanosized metal wear debris formed by tribochemical reaction as confirmed by high-resolution TEM and XPS analyses. J. Biomed. Mater. Res. A 2009, 91:1100-1110.
31. Scott M., Widding K., Jani S. Do current wear particle isolation procedures underestimate the number of particles generated by prosthetic bearing components?. Wear 2001, 251:1213-1217.
32. Richards L., Brown C., Stone M.H., Fisher J., Ingham E., Tipper J.L. Identification of nanometre-sized ultra-high molecular weight polyethylene wear particles in samples retrieved in vivo. J. Bone Jt. Surg. Br. 2008, 90:1106-1113.
33. Doorn P.F., Campbell P.A., Worrall J., Benya P.D., McKellop H.A., Amstutz H.C. Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J. Biomed. Mater. Res. 1998, 42:103-111.
34. Benz E.B., Federman M., Godleski J.J., Bierbaum B.E., Thornhill T.S., Spector M. Transmission electron microscopy of intracellular particles of polyethylene from joint replacement prostheses: size distribution and cellular response. Biomaterials 2001, 22:2835-2842.
35. Hatton A., Nevelos J.E., Nevelos A.A., Banks R.E., Fisher J., Ingham E. Alumina-alumina artificial hip joints. Part I: a histological analysis and characterisation of wear debris by laser capture microdissection of tissues retrieved at revision. Biomaterials 2002, 23:3429-3440.
36. Topolovec M., Cor A., Milošev I. Metal-on-metal vs. metal-on-polyethylene total hip arthroplasty tribological evaluation of retrieved components and periprosthetic tissue. J. Mech. Behav. Biomed. Mater. 2014, 34:243-252.
37. Nel A., Xia T., Mädler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
38. Campbell P., Ma S., Schmalzried T., Amstutz H.C. Tissue digestion for wear debris particle isolation. J. Biomed. Mater. Res. 1994, 28:523-526.
39. Fernández-García M., Rodriguez J.A. Metal oxide nanoparticles. Nanomaterials: Inorganic and Bioinorganic Perspectives 2007, John Wiley & Sons, Inc., New Jersey. C.M. Lukehart, R.A. Scott (Eds.).
40. McHale J.M., Auroux A., Perrotta A.J., Navrotsky A. Surface energies and thermodynamic phase stability in nanocrystalline aluminas. Science 1997, 277:788-791.
41. Lapcikova M., Slouf M., Dybal J., Zolotarevova E., Entlicher G., Pokorny D., et al. Nanometer size wear debris generated from ultra high molecular weight polyethylene in vivo. Wear 2009, 266:349-355.
42. Iyengar V., Woittiez J. Trace elements in human clinical specimens: evaluation of literature data to identify reference values. Clin. Chem. 1988, 34:474-481.
43. Vanhoe H. A review of the capabilities of ICP-MS for trace element analysis in body fluids and tissues. J. Trace Elem. Electrol. Health Dis. 1993, 7:131-139.
44. Pace H.E., Rogers N.J., Jarolimek C., Coleman V.A., Higgins C.P., Ranville J.F. Determining transport efficiency for the purpose of counting and sizing nanoparticles via single particle inductively coupled plasma mass spectrometry. Anal. Chem. 2011, 83:9361-9369.
45. Gray E.P., Coleman J.G., Bednar A.J., Kennedy A.J., Ranville J.F., Higgins C.P. Extraction and analysis of silver and gold nanoparticles from biological tissues using single particle inductively coupled plasma mass spectrometry. Environ. Sci. Technol. 2013, 47:14315-14323.
46. Fraikin J.L., Teesalu T., McKenney C.M., Ruoslahti E., Cleland A.N. A high-throughput label-free nanoparticle analyser. Nat. Nanotechnol. 2011, 6:308-313.
47. Nine M.J., Choudhury D., Hee A.C., Mootanah R., Osman N.A.A. Wear debris characterization and correponding biological response: artificial hip and knee joints. Materials 2014, 7:980-1016.
48. Catelas I., Bobyn J.D., Medley J.B., Krygier J.J., Zukor D.J., Petit A., et al. Effects of digestion protocols on the isolation and characterization of metal-metal wear particles. I. Analysis of particle size and shape. J. Biomed. Mater. Res. 2001, 55:320-329.
49. Hassellov M., Readman J.W., Ranville J.F., Tiede K. Nanoparticle analysis and characterization methodologies in environmental risk assessment of engineered nanoparticles. Ecotoxicology 2008, 17:344-361.
50. Dulski T.R. A Manual for the Chemical Analysis of Metals 1996, ASTM International. first ed.
51. Izak-Nau E., Voetz M., Eiden S., Duschl A., Puntes V.F. Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation. Part. Fibre Toxicol. 2013, 10.
52. Tenzer S., Docter D., Kuharev J., Musyanovych A., Fetz V., Hecht R., et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 2013, 8:772-781.
53. Hajipour M.J., Laurent S., Aghaie A., Rezaee F., Mahmoudi M. Personalized protein coronas: a "key" factor at the nanobiointerface. Biomater. Sci. 2014, 2:1210-1221.
54. Mortensen N.P., Hurst G.B., Wang W., Foster C.M., Nallathamby P.D., Retterer S.T. Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. Nanoscale 2013, 5:6372-6380.
55. Pascual E., Jovaní V. Synovial fluid analysis. Best. Pract. Res. Clin. Rheumatol. 2005, 19:371-386.
56. Lacerda S.H., Park J.J., Meuse C., Pristinski D., Becker M.L., Karim A., et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 2010, 4:365-379.
57. Xu M., Li J., Iwai H., Mei Q., Fujita D., Su H., et al. Formation of nano-bio-complex as nanomaterials dispersed in a biological solution for understanding nanobiological interactions. Sci. Rep. 2012, 2:406.
58. Kapralov A.A., Feng W.H., Amoscato A.A., Yanamala N., Balasubramanian K., Winnica D.E., et al. Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 2012, 6:4147-4156.
59. ASTM ASTM Standard F561-13: Standard Practice for Retrieval and Analysis of Medical Devices, and Associated Tissues and Fluids 2013, ASTM International, Available from: URL:. http://www.astm.org/Standards/F561.htm.
60. ISO. 17583:2011(en) Wear of implant materials - Polymer and Metal Wear particles - Isolation and characterization. Geneva, Switzerland: International Organization for Standardization. Online. 2011 March. Available from URL: . http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=57230.
61. Billi F., Benya P., Kavanaugh A., Adams J., Ebramzadeh E., McKellop H. The John Charnley Award: an accurate and sensitive method to separate, display, and characterize wear debris: part 1: polyethylene particles. Clin. Orthop. Relat. Res. 2012, 470:329-338.
62. Billi F., Benya P., Kavanaugh A., Adams J., McKellop H., Ebramzadeh E. The John Charnley Award: an accurate and extremely sensitive method to separate, display, and characterize wear debris: part 2: metal and ceramic particles. Clin. Orthop. Relat. Res. 2012, 470:339-350.
63. Thrivikraman G., Madras G., Basu B. In vitro/In vivo assessment and mechanisms of toxicity of bioceramic materials and its wear particulates. RSC Adv. 2014, 4:12763-12781.
64. Gatti A.M., Rivasi F. Biocompatibility of micro- and nanoparticles. Part I: in liver and kidney. Biomaterials 2002, 23:2381-2387.
65. Gatti A.M. Biocompatibility of micro- and nano-particles in the colon. Part II. Biomaterials 2004, 25:385-392.
66. Lai S.K., Wang Y.Y., Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 2009, 61:158-171.
67. Collnot E.M., Ali H., Lehr C.M. Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J. Control. Release 2012, 161:235-246.
68. Gatti A.M., Montanari S., Monari E., Gambarelli A., Capitani F., Parisini B. Detection of micro- and nano-sized biocompatible particles in the blood. J. Mater. Sci. Mater. Med. 2004, 15:469-472.
69. Gatti A.M., Montanari S. Retrieval analysis of clinical explanted vena cava filters. J. Biomed. Mater. Res. B Appl. Biomater. 2006, 77:307-314.
70. Song Y., Li X., Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur. Respir. J. 2009, 34:559-567.
71. Wu M., Gordon R.E., Herbert R., Padilla M., Moline J., Mendelson D., et al. Case report: lung disease in World Trade Center responders exposed to dust and smoke: carbon nanotubes found in the lungs of World Trade Center patients and dust samples. Environ. Health Perspect. 2010, 118:499-504.
72. Theegarten D., Boukercha S., Philippou S., Anhenn O. Submesothelial deposition of carbon nanoparticles after toner exposition: case report. Diagn. Pathol. 2010, 5.
73. Song Y., Li X., Wang L., Rojanasakul Y., Castranova V., Li H., et al. Nanomaterials in humans: identification, characteristics, and potential damage. Toxicol. Pathol. 2011, 39:841-849.
74. Elsaesser A., Barnes C.A., McKerr G., Salvati A., Lynch I., Dawson K.A., et al. Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. Nanomedicine 2011, 6:1189-1198.
75. Elsaesser A., Taylor A., de Yanés G.S., McKerr G., Kim E.-M., O'Hare E., et al. Quantification of nanoparticle uptake by cells using microscopical and analytical techniques. Nanomedicine 2010, 5:1447-1457.
76. Brown S.C., Boyko V., Meyers G., Voetz M., Wohlleben W. Toward advancing nano-object count metrology: a best practice framework. Environ. Health Perspect. 2013, 121:1282-1291.
77. NSTC: Subcommittee on Nanoscale Science, Engineering and Technology. Progress Review on the Coordinated Implementations of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy. USA: National Science and Technology Council. Online. 2014 June. Available from URL: . http://www.nano.gov/sites/default/files/pub_resource/2014_nni_ehs_progress_review.pdf.